The associated phenotypic changes and the potential for resistance transfer via TDEs have been evaluated, and the results indicate that intercellular transfer of P-gp enables drug-sensitive cells to develop DOX resistance in breast cancer [121]. This evidence concerns the gene PGP and breast carcinoma.